Cytomegalovirus retinitis in the post-cART era
- PMID: 30886765
- PMCID: PMC6419753
- DOI: 10.1007/s40135-018-0173-4
Cytomegalovirus retinitis in the post-cART era
Abstract
Purpose of review: To review the epidemiology, diagnosis, and management of cytomegalovirus retinitis (CMVR) in the post-combined antiretroviral era (cART) era.
Recent findings: Although cART has dramatically reduced CMVR incidence and morbidity in the HIV population, CMVR continues to cause significant vision loss in both HIV and non-HIV patients, especially amongst patients without immune reconstitution. Advances in imaging including ultra-widefield fundus and autofluorescence imaging, optical coherence tomography, and adaptive optics may reflect CMVR activity; however, the diagnosis remains a clinical one. There have been minimal advances in therapy, with several agents no longer available due to market concerns.
Summary: Despite reduced incidence and morbidity in the post-cART HIV population, CMVR continues to cause vision loss amongst HIV and non-HIV patients. Diagnosis remains primarily clinical, and therapy centers upon immune reconstitution along with systemic and/or intravitreal antivirals. Further studies are necessary to determine whether advanced imaging can influence management, and whether novel antiviral agents or adoptive immune transfer have a role in treatment of drug-resistance CMVR.
Keywords: HAART; cART; cytomegalovirus retinitis.
Figures
References
-
- Holbrook JT, Jabs DA, Weinberg DV, et al. (2003) Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol Chic Ill 1960 121:99–107 - PubMed
-
- Hoover DR, Peng Y, Saah A, et al. (1996) Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol Chic Ill 1960 114:821–827 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials